Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Lung Adenocarcinoma
100%
Immune Infiltration
100%
SQSTM1
100%
Peripheral Immune Cells
100%
Immune Cell Infiltration
33%
Immune Infiltration Level
22%
Poor Prognosis
11%
Immune Cells
11%
Lymphocytes
11%
Expression Level
11%
Cell Proliferation
11%
Tumor-infiltrating Lymphocytes
11%
Negatively Associated
11%
Methylation Status
11%
Cancer Progression
11%
Predictive Marker
11%
Prognostic Marker
11%
Progression-free Survival
11%
Tumor-infiltrating Immune Cells
11%
Tumor Samples
11%
Tumor Infiltration
11%
Role in Cancer
11%
Retrospective Cohort Analysis
11%
Epithelial-mesenchymal Transition
11%
Potential Prediction
11%
Preclinical Experiment
11%
Proliferation Migration
11%
Immune-related
11%
Immunotherapy Targets
11%
Geodatabase
11%
Lung Adenocarcinoma Cells
11%
Somatic Copy number Alterations
11%
Immune Checkpoint Therapy
11%
Cell Status
11%
ESTIMATE Algorithm
11%
Limma
11%
Differential Expression Genes
11%
Immune Checkpoint Inhibitors
11%
Small Cohorts
11%
Migration/invasion
11%
Single-sample Gene Set Enrichment Analysis (ssGSEA)
11%
Immunology and Microbiology
Immune Response
100%
Immunotherapy
100%
Immune Cell Infiltration
100%
Lung
100%
Immunocompetent Cell
33%
Immune Checkpoint Inhibitor
22%
Tumor-Infiltrating Lymphocytes
11%
Cell Proliferation
11%
Methylation
11%
Epithelial Mesenchymal Transition
11%
Progression Free Survival
11%
Lung Adenocarcinoma Cell Line
11%
Lymphocyte
11%
Differential Gene Expression
11%
In Vitro
11%